YOLFTbeta
NS

Nestmedic S.A.

NST · WAR · Healthcare / Medical Devices

0.702PLN+0.01 (+1.15%)

Price History

Full chart

Market Stats

Previous Close0.694
Open0.694
Day Range0.686 – 0.724
52-Week Range0.49 – 0.875
Volume22.55K
Market Cap11.36M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.3327
Dividend Yield0.00%
50-Day Avg0.00
200-Day Avg0.00

About

Nestmedic S.A., together with its subsidiaries, manufactures telemedicine solutions under the Pregnabit brand. The company offers Pregnabit Pro, a medical device for measuring fetal heart rate, uterine contraction activity, and signaling fetal movements; Pregnabit Cloud, a SaaS system for telemedical CTG devices; and Pregnabit system comprising the mobile CTG device and the medical telemonitoring center service. It sells its products through a distribution network and resellers worldwide. The company was incorporated in 2017 and is headquartered in Warsaw, Poland.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jacek Marek Gnich
  • Employees3
  • Headquartersul. Pasymska 20, Warsaw, Poland, 01-993, Poland
  • Websitehttps://www.nestmedic.com

Leadership

  • Mr. Jacek Marek GnichPresident of the Management Board
  • Ms. Beata Anna Turlejska?ZdunczykVice-President of the Management Board
  • Ms. Anna SkotnyCo-founder
  • Mr. Milosz JamrozyDirector for Technology & Development
  • Dr. Ewelina Swiderek Ph.D.Medical & Scientific Affairs Director
  • Mr. Robert WoytonMedical Director & President of Medical Telemonitoring Center

Financials

Income Statement

Currency: PLN2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue7.82K51.04K119.41K474.21K382.37K654.57K1.87M1.55M969.20K846.37K
Growth (%)-+552.69%+133.95%+297.13%-19.37%+71.19%+185.23%-17.08%-37.39%-12.67%
Cost of Revenue81.31K196.44K174.02K208.23K130.14K558.91K1.06M595.83K314.39K204.83K
Gross Profit-73.49K-145.40K-54.61K265.98K252.23K95.66K809.58K952.25K654.81K641.54K
Gross Margin-939.77%-284.87%-45.73%56.09%65.96%14.61%43.36%61.51%67.56%75.80%
Operating Expense973.95K4.18M4.04M3.40M2.53M3.92M7.52M7.27M5.70M4.77M
Operating Income-1.05M-4.32M-4.10M-3.13M-2.27M-3.82M-6.71M-6.32M-5.05M-4.13M
Operating Margin-13394.37%-8472.51%-3432.34%-661.05%-594.66%-583.99%-359.46%-408.12%-520.86%-487.47%
EBITDA---3.93M-3.12M-3.84M-3.31M-4.27M-5.80M-4.12M-3.40M
EBITDA Margin---3291.42%-658.24%-1003.48%-506.04%-228.55%-374.84%-424.87%-401.75%
Net Income-1.06M-4.29M-4.10M-3.38M-2.35M-3.91M-4.95M-6.77M-5.38M-4.60M
Net Income Margin-13599.23%-8411.62%-3435.11%-712.46%-615.73%-596.66%-265.30%-437.32%-555.11%-543.36%
Interest Expense003.97K97.25K304.80K370.63K306.11K413.36K216.27K247.49K
Interest Expense % of Total Revenue0.00%0.00%3.33%20.51%79.71%56.62%16.40%26.70%22.31%29.24%

Balance Sheet

Currency: PLN2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.99M11.60M8.49M6.60M7.24M10.57M14.16M12.67M11.21M15.12M
Total Liabilities323.61K6.17M5.84M6.60M8.84M9.58M10.84M7.31M8.13M7.00M
Total Equity1.67M5.43M2.65M6.79K-1.59M988.58K3.33M5.36M3.08M8.12M
Cash150-541.04K2.05M320.48K2.32M769.96K101.25K270.64K1.62M
Total Debt150.00K---------
Net Debt-------683.70K712.31K-

Cash Flow

Currency: PLN2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.20M-2.86M-2.59M-1.77M-7.80M-8.21M-6.67M-4.31M-7.27M
Investing Cash Flow-349.90K-1.02M-981.65K-2.34M-----
Financing Cash Flow7.90M1.32M5.07M2.38M-----
Capital Expenditure349.90K1.10M988.32K2.34M267.35K272.38K11.10K00
Free Cash Flow--3.96M-3.57M-4.05M-8.07M-8.49M-6.68M-4.31M-7.27M
FCF to OCF-138.36%138.22%228.88%103.43%103.32%100.17%100.00%100.00%

Earnings

Report DateMar 31, 2018Aug 12, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------
EPS Actual-0.21-0.20-0.18-0.11-0.12-0.08-0.15-0.13-0.06-0.05-0.08-0.15-0.07-0.08-0.09-0.130.03-0.10-0.10-0.07-0.09-0.07-0.07-0.04-0.07-0.04-0.05-0.03-0.03-0.03-0.03-0.02-0.01
Surprise---------------------------------
Timing-After-hours-------------------------------

Key Statistics & Ratios

Market Cap11.36M
Enterprise Value0
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.00
EPS-0.3327
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding0
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%